Skip to main content

letter

. 1994 Jan 8;308(6921):133. doi: 10.1136/bmj.308.6921.133c

Long-term management after splenectomy. Consider prophylaxis in systematic lupus erythematosus.

K A Davies, H L Beynon, M J Walport

PMCID: PMC2539230 PMID: 8298397

133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Breban M., Meyer O., Bourgeois P., Palazzo E., Kahn M. F. The actual survival rate in systemic lupus erythematosus: study of a 1976 cohort. Clin Rheumatol. 1991 Sep;10(3):283–288. doi: 10.1007/BF02208691. [DOI] [PubMed] [Google Scholar]
Cohen M. G., Li E. K. Mortality in systemic lupus erythematosus: active disease is the most important factor. Aust N Z J Med. 1992 Feb;22(1):5–8. doi: 10.1111/j.1445-5994.1992.tb01700.x. [DOI] [PubMed] [Google Scholar]
Davies K. A., Erlendsson K., Beynon H. L., Peters A. M., Steinsson K., Valdimarsson H., Walport M. J. Splenic uptake of immune complexes in man is complement-dependent. J Immunol. 1993 Oct 1;151(7):3866–3873. [PubMed] [Google Scholar]
McMullin M., Johnston G. Long term management of patients after splenectomy. BMJ. 1993 Nov 27;307(6916):1372–1373. doi: 10.1136/bmj.307.6916.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
Mitchell S. R., Nguyen P. Q., Katz P. Increased risk of neisserial infections in systemic lupus erythematosus. Semin Arthritis Rheum. 1990 Dec;20(3):174–184. doi: 10.1016/0049-0172(90)90058-n. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES